Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00004071
What this trial is testing

Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00293371
What this trial is testing

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 6
Testing effectiveness (Phase 2)Study completedNCT00706498
What this trial is testing

Phase II Study of BI 2536 in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT01187485
What this trial is testing

Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 15
Large-scale testing (Phase 3)Study completedNCT00046943
What this trial is testing

Atrasentan in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abbott
Early research (Phase 1)Study completedNCT01273168
What this trial is testing

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Who this might be right for
Hormone Receptor-Positive BreastGynecologicDesmoid+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00912340
What this trial is testing

Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Emory University 70
Large-scale testing (Phase 3)Study completedNCT01824342
What this trial is testing

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Amgen 18
Testing effectiveness (Phase 2)Study completedNCT00473746
What this trial is testing

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 66
Not applicableWithdrawnNCT02867345
What this trial is testing

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Peking University
Testing effectiveness (Phase 2)Ended earlyNCT00786682
What this trial is testing

Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey 11
Not applicableWithdrawnNCT01692483
What this trial is testing

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Pharmaceutica
Early research (Phase 1)UnknownNCT00009750
What this trial is testing

Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00003781
What this trial is testing

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
PainProstate Cancer
OHSU Knight Cancer Institute 25
Early research (Phase 1)Study completedNCT00010231
What this trial is testing

Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Pittsburgh 22
Testing effectiveness (Phase 2)Study completedNCT00201357
What this trial is testing

An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
National Health Research Institutes, Taiwan 30
Testing effectiveness (Phase 2)Study completedNCT00337155
What this trial is testing

BAY88-8223, Dose Finding Study in Patients With HRPC

Who this might be right for
Prostate CancerNeoplasm Metastasis
Bayer 122
Large-scale testing (Phase 3)Study completedNCT00005947
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dendreon 127
Testing effectiveness (Phase 2)Study completedNCT00283829
What this trial is testing

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Next Page